Heart Science and Therapeutics
Heart Science and Therapeutics integrates pharmacologic knowledge and clinical decision-making to optimize patient management of heart diseases through evidence-based pharmacotherapy and drug monitoring.
Summary
Lectures are large, with a median of 129 enrolled students in the recorded sections.
What you’ll be able to do
Assess heart conditions by evaluating diagnostic criteria, risk factors, etiology, and treatment goals.
Differentiate among the therapeutic drug classes based on mechanisms of action, clinical use, adverse effects, contraindications, interactions, and dosage forms used for heart conditions.
Explain why a drug is selected for a specific heart condition or person based on its properties.
Design a person-centered care plan consisting of both drug and non-drug elements appropriate for an individual with heart disease using evidence-based principles and guidelines.
Evaluate a person-centered care plan to optimize safety and efficacy, considering patient-specific factors, to improve therapeutic outcomes for heart conditions.
Source: UW Guide
Grade history
↗No recorded grade history.
All recorded terms · compare terms & instructors
Prerequisites
Course mapPHARMACY 435
“Used by” includes alternatives; linked courses may have other requirements. This is a best-effort interpretation; check the catalog requirements above.
Prerequisite text tree
Professors
Spring 2027No instructors recorded for this selection.
Historical instructors & teaching patterns
Recorded history may be incomplete and does not establish a future schedule.
Calendar & sections
Spring 2027Schedule loads here as you scroll.
| Section | Mode | Enrolled / capacity | Waitlist |
|---|
Times are Central. Select a meeting for details; export includes recorded dates for the selected sections.
Meeting source records
Student experience
the class
Integration of pharmacologic knowledge and clinical decision-making to optimize patient management of heart diseases. Emphasis on patient assessment and provision of evidence-based practices through application of pharmacotherapy principles, and drug monitoring to support person-centered care.
difficulty & workload
No workload feedback recorded.
Topics
- Patient management of heart diseases
- Patient assessment and evidence-based practices
- Pharmacotherapy principles and drug monitoring
- Person-centered care
Skills
- Assess heart conditions using diagnostic criteria, risk factors, etiology, and treatment goals.
- Differentiate cardiac therapeutic drug classes by mechanism, use, adverse effects, contraindications, interactions, and dosage forms.
- Explain drug selection for specific heart conditions or persons based on drug properties.
- Design person-centered care plans with drug and non-drug elements for heart disease using evidence-based principles.
- Evaluate person-centered care plans to optimize safety and efficacy for heart conditions.
Grades
Grade distribution · % of letter grades
No grades available yet.
More grade details Grade mix, volume & source data
Sources & history
Catalog & offerings
Descriptions, prerequisites, and recorded course offerings.
Catalog observation history
Observations at scan time; dates do not imply when a catalog change took effect.
Selected offering source records
No offering records for the selected term.
Raw records
[]
Student reviews
Original comments behind the course and instructor summaries.
Read original reviews
No records available.
Grade history
Recorded grade distributions by term, section, and instructor.
Explore recorded gradesRecorded 2026-10-14
Model outputs & technical records
LLM outputs across runs
Full model traces
Recorded model configuration, reasoning, and tool conversations.
Model & dataset provenance
{
"model": "Qwen/Qwen3.8-27B",
"model_revision": "1d4bf0f2ff6012fd82039f2fa52739d0dd7c60c0",
"task_version": "17",
"output_id": "dc67f742c5abd816bda41d80232a94c6461b8818f75c3c03e6f41dad8b70c762",
"requirements_status": "valid",
"dataset_revision": "fc1811fa52e581ea57a35c0cf3343f8740a8ffbf",
"observed_at": "2026-10-14 17:50:09.728220+00:00"
}